Emro엠로
058970 · KOSDAQ · ₩058970 · 엠로
What brokers say about Emro
Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.
AI summary of public information
An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.
Emro's trailing revenue is holding up, but the business is barely profitable and its shares have fallen sharply over the past year.
Emro is an AI-based supply chain management software company serving large Korean corporations, with a SaaS procurement system and an overseas push through its Caidentia platform. For the twelve months to H1 2026 it reported revenue of about ₩72.4B, an operating loss of about ₩3.4B, and a small net profit of about ₩0.4B. The share price closed at ₩14,850 on 22 October 2026, down 66.4% over one year and well below its 52-week high of ₩47,150.
What stands out
- Revenue rose from ₩44.1B in 2021 to ₩80.9B in 2025, but operating margin fell from 15.6% to 2.4% over the same period.
- Trailing operating margin is -4.7%, so the small trailing net profit appears to rest on items other than core operations; the data does not explain what they are.
- 2023 showed a large net loss of ₩27.3B, while 2024 net income of ₩18.7B was well above operating income, so reported earnings have been volatile.
- Valuation metrics are high relative to earnings: trailing P/E is about 436 and the DCF base fair value is ₩9,426, below the current price, with bear and bull values of ₩6,016 and ₩15,053.
- Cash of ₩17.7B against no reported borrowings, with liabilities at 17.3% of equity, and foreign ownership fell from 3.9% to 2%.
What to watch
- A major sales or supply contract was filed on 20 October 2026; the filing's terms are not in the data, so its size and effect are unknown.
- The next half-year or annual results and any further amended filings, given recent restatements of the 2025 annual and March 2026 quarterly reports.
- A CEO change was filed in July 2026 and stock option grants were amended; the data does not say how these affect strategy or dilution.
Data as of Oct 22, 2026 · written 4d ago
This is not financial advice.
Also known as: Emro / 엠로 / 058970 / KRX:058970
Source: KRX statistical information